The United States Urinalysis Market dominates North America due to high diagnostic testing volumes and strong penetration of advanced laboratory automation systems. The increasing prevalence of diabetes, chronic kidney disease, and urinary tract infections is driving consistent demand for urinalysis in both clinical and home-care settings.

Global Urinalysis Market Developments indicate a steadily evolving industry driven by technological innovation, expanding healthcare access, and increasing testing volumes across developed and emerging economies. Laboratory automation, improved reagent technologies, and growing awareness surrounding preventive healthcare are transforming diagnostic workflows across hospitals and clinical laboratories. According to The Insight Partners, The urinalysis market is projected to reach US$ 5,937.97 million by 2028 from US$ 4,065.79 million in 2021; it is expected to grow at a CAGR of 5.6% from 2021 to 2028.  

Get Sample PDF @ https://www.theinsightpartners.com/sample/TIPHE100001381

Rising Prevalence of Chronic Diseases Driving Industry Expansion

One of the major factors contributing to industry expansion is the growing burden of chronic diseases requiring routine diagnostic monitoring. Urinalysis plays a critical role in detecting abnormalities associated with kidney disease, diabetes mellitus, liver dysfunction, and urinary tract infections.

The increasing global diabetic population has significantly contributed to testing demand. Diabetes often leads to kidney-related complications, making urine analysis a routine screening procedure for millions of patients worldwide. Similarly, urinary tract infections remain among the most frequently diagnosed bacterial infections globally, particularly among women and elderly populations.

Healthcare providers are increasingly adopting urine testing as an affordable and non-invasive diagnostic approach, further supporting sector growth over the forecast period.

Technological Advancements Reshaping Diagnostic Testing

Technology innovation remains a defining factor influencing industry development. Automated urine analyzers are replacing traditional manual microscopy methods, enabling faster processing times, reduced human error, and improved diagnostic accuracy.

Artificial intelligence integration in automated analyzers is improving interpretation efficiency while reducing laboratory workload. Digital imaging systems, automated strip readers, and advanced reagent chemistry are further enhancing test reliability.

Portable and compact diagnostic devices are also becoming increasingly popular for decentralized healthcare environments, allowing faster testing in outpatient clinics and home healthcare settings.

Product Segmentation Highlights Growing Consumables Demand

Based on product segmentation, consumables continue to represent the dominant category due to recurring demand for test strips, reagents, disposable containers, and related diagnostic supplies. Consumables accounted for nearly 65.9% of total industry share in 2021.

Diagnostic laboratories and hospitals rely heavily on continuous replenishment of these supplies, creating stable long-term demand patterns. Instruments, including automated analyzers and microscopy systems, are also experiencing increasing adoption as healthcare facilities modernize laboratory infrastructure.

Among test categories, biochemical urinalysis and sediment urinalysis remain highly important due to their broad application in disease detection and clinical screening programs.

Regional Trends Creating Growth Opportunities

Geographically, North America maintained the leading share with approximately 35.2% revenue contribution in 2021, supported by advanced healthcare infrastructure, widespread insurance coverage, and strong adoption of laboratory automation technologies.

Asia Pacific is emerging as the fastest-growing region, projected to expand at a CAGR of approximately 6.4% during the forecast period. Rapid healthcare infrastructure development in countries such as India, China, and Japan continues to improve access to diagnostic services.

The United States remains a particularly important contributor, with projected growth of approximately 6.1% during the forecast timeline through 2028.

Competitive Landscape and Strategic Industry Developments

Leading companies continue focusing on product innovation, acquisitions, partnerships, and regional expansion strategies to strengthen global presence and meet rising diagnostic demand. Major participants are investing heavily in automation technologies and advanced testing solutions.

Key industry participants include:

• Abbott Laboratories
• Cardinal Health
• F. Hoffmann-La Roche Ltd
• Beckman Coulter
• Sysmex Corporation
• Bio-Rad Laboratories
• Siemens Healthineers AG
• QuidelOrtho Corporation

Strategic partnerships and acquisitions are enabling companies to strengthen distribution networks while expanding product portfolios in emerging healthcare economies.

Impact of Post-Pandemic Healthcare Recovery

The COVID-19 pandemic initially disrupted diagnostic testing volumes due to delayed hospital visits, lockdown restrictions, and supply chain interruptions. However, healthcare systems have gradually resumed routine testing activities.

Renewed emphasis on preventive healthcare and chronic disease management has restored demand for urine testing procedures. Healthcare institutions are increasing investments in laboratory modernization to improve preparedness for future healthcare disruptions.

Future Outlook

The global urinalysis industry is expected to maintain steady expansion through 2028, supported by growing chronic disease prevalence, expanding diagnostic infrastructure, and continued automation advancements. Increasing adoption of home-based diagnostic solutions, stronger healthcare investments in emerging economies, and continuous product innovation will shape future development.

Related Report:

1) C-Reactive Protein Rapid Test Market Growth, Demand & Size by 2034

2) Mesotherapy Market Size and Growth 2031

3) Anti-Acne Cosmetics Market Overview, Growth, Trends, Analysis, Research Report (2021-2031)

About Us -

The Insight Partners provides comprehensive syndicated and tailored market research services in the healthcare, technology, and industrial domains. Renowned for delivering strategic intelligence and practical insights, the firm empowers businesses to remain competitive in ever-evolving global markets.

Contact Us:
Ankit Mathur | The Insight Partners
E-mail: ankit.mathur@theinsightpartners.com
Phone: +1-646-491-9876

Also Available in : Korean German Japanese French Chinese Italian Spanish